Literature DB >> 23345948

Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.

Takanori Hosokawa1, Masayuki Kurosaki, Kaoru Tsuchiya, Shuya Matsuda, Masaru Muraoka, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Toru Nakata, Takashi Nishimura, Shoko Suzuki, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Namiki Izumi.   

Abstract

AIM: To evaluate whether metabolic factors are related to distant recurrence of hepatocellular carcinoma (HCC) and survival after curative treatment.
METHODS: This retrospective study included 344 patients whose HCC was treated curatively by radiofrequency ablation (RFA) therapy. The mean age was 67.6 years and the mean observation period was 4.04 years. The etiological background of liver disease was hepatitis B virus infection in 30, hepatitis C virus infection in 278, excessive alcohol drinking in 9, and other in 27 patients. The Child-Pugh classification grade was A (n = 307) or B (n = 37). The number of HCC nodules was one in 260, two in 61, and three in 23 patients. For surveillance of HCC recurrence after curative therapy with RFA, patients were radiologically evaluated every 3 mo. Factors associated with distant recurrence of HCC or survival were studied.
RESULTS: Inadequate maintenance of blood glucose in diabetic patients was associated with higher incidence of distant recurrence. The 1-, 2-, and 3-year recurrence rates were significantly higher in diabetic patients with inadequate maintenance of blood glucose compared with the others: 50.6% vs 26.8%, 83.5% vs 54.4%, and 93.8% vs 73.0%, respectively (P = 0.0001). Inadequate maintenance of blood glucose was an independent predictor of distant recurrence [adjusted relative risk 1.97 (95%CI, 1.33-2.91), (P = 0.0007)] after adjustment for other risk factors, such as number of HCC nodules [2.03 (95%CI, 1.51-2.73), P < 0.0001] and initial level of serum alpha fetoprotein (AFP) [1.43 (95%CI, 1.04-1.97), P = 0.028]. Obesity was not an independent predictor of recurrence. The incidence of distant recurrence did not differ between diabetic patients with adequate maintenance of blood glucose and non-diabetic patients. Among 232 patients who had HCC recurrence, 138 had a second recurrence. The 1-, 2-, and 3-year rates of second recurrence were significantly higher in diabetic patients with inadequate maintenance of blood glucose than in the others: 9.0% vs 5.9%, 53.1% vs 24.3%, and 69.6% vs 42.3%, respectively (P = 0.0021). Inadequate maintenance of blood glucose in diabetic patients [1.99 (95%CI, 1.23-3.22), P = 0.0049] and presence of multiple HCC nodules [1.53 (95%CI, 1.06-2.22), P = 0.024] were again significantly associated with second HCC recurrence. Inadequate maintenance of blood glucose in diabetic patients was also a significant predictor of poor survival [2.77 (95%CI, 1.38-5.57), P = 0.0046] independent of excessive alcohol drinking [6.34 (95%CI, 1.35-29.7), P = 0.019], initial level of serum AFP [3.40 (95%CI, 1.88-6.18), P < 0.0001] and Child-Pugh classification grade B [2.24 (95%CI, 1.12-4.46), P = 0.022]. Comparing diabetic patients with inadequate maintenance of blood glucose vs the others, the 1-, 2-, and 3-year survival rates were significantly lower in diabetic patients with inadequate maintenance of blood glucose: 92% vs 99%, 85% vs 96%, and 70% vs 92%, respectively (P = 0.0003).
CONCLUSION: Inadequate maintenance of blood glucose in diabetic patients is a significant risk factor for recurrence of HCC and for poor survival after curative RFA therapy.

Entities:  

Keywords:  Hepatocellular carcinoma; Hyperglycemia; Radio frequency ablation; Recurrence; Survival

Mesh:

Substances:

Year:  2013        PMID: 23345948      PMCID: PMC3547569          DOI: 10.3748/wjg.v19.i2.249

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Linking diabetes and cancer: a consensus on complexity.

Authors:  Andrew Renehan; Ulf Smith; M Sue Kirkman
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

2.  Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis.

Authors:  Nobuhiro Aizawa; Hirayuki Enomoto; Hiroyasu Imanishi; Masaki Saito; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Yoshiyuki Sakai; Tomoyuki Takashima; Takashi Iwai; Ei-Ichiro Moriwaki; Soji Shimomura; Hiroko Iijima; Hideji Nakamura; Shuhei Nishiguchi
Journal:  World J Hepatol       Date:  2012-01-27

3.  Diabetes may not affect outcomes in hepatocellular carcinoma after radio-frequency ablation.

Authors:  Wei-Ting Chen; Therese Capalongan Macatula; Chen-Chun Lin; Chun-Jung Lin; Shi-Ming Lin
Journal:  Hepatogastroenterology       Date:  2011 Mar-Apr

4.  Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma.

Authors:  H Toyoda; T Kumada; S Nakano; I Takeda; K Sugiyama; S Kiriyama; M Tanikawa; Y Sone; Y Hisanaga
Journal:  Cancer       Date:  2001-03-01       Impact factor: 6.860

5.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

Review 6.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Authors:  Masatoshi Kudo; Hobyung Chung; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

8.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 9.  The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Authors:  Edward Giovannucci; Dominique Michaud
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

Review 10.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.

Authors:  Hashem B El-Serag; Howard Hampel; Fariba Javadi
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

View more
  16 in total

1.  The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.

Authors:  M Zhou; M T Mok; H Sun; A W Chan; Y Huang; A S Cheng; G Xu
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

2.  NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.

Authors:  Charupong Saengboonmee; Chatchai Phoomak; Suangson Supabphol; Kyle R Covington; Oliver Hampton; Chaisiri Wongkham; Richard A Gibbs; Kazuo Umezawa; Wunchana Seubwai; Marie-Claude Gingras; Sopit Wongkham
Journal:  Life Sci       Date:  2020-10-07       Impact factor: 5.037

3.  Antidiabetic treatment improves prognosis after radical resection in hepatocellular carcinoma patients with diabetes mellitus: a retrospective cohort study from 2000 to 2013.

Authors:  Jing-Zhu Cao; Zhen-Guang Wang; Jian Yu; Yuan-Ping Tao; Yuan Yang; Hui Liu; Wei-Ping Zhou; Jin Lu; Qin Huang
Journal:  J Gastrointest Oncol       Date:  2022-06

4.  High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells.

Authors:  Hande Topel; Ezgi Bağırsakçı; Yeliz Yılmaz; Ayşim Güneş; Gülsün Bağcı; Dehan Çömez; Erkan Kahraman; Peyda Korhan; Neşe Atabey
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

Review 5.  Hyperglycemia as a risk factor for cancer progression.

Authors:  Tae Young Ryu; Jiyoung Park; Philipp E Scherer
Journal:  Diabetes Metab J       Date:  2014-10       Impact factor: 5.376

Review 6.  Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight.

Authors:  Juan Carlos Laguna; Marta Alegret; Núria Roglans
Journal:  Nutrients       Date:  2014-12-22       Impact factor: 5.717

7.  Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.

Authors:  Surbhi Chouhan; Snahlata Singh; Dipti Athavale; Pranay Ramteke; Vimal Pandey; Jomon Joseph; Rajashekar Mohan; Praveen Kumar Shetty; Manoj Kumar Bhat
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

8.  High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation.

Authors:  Charupong Saengboonmee; Wunchana Seubwai; Chawalit Pairojkul; Sopit Wongkham
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

9.  Dietary sugar intake increases liver tumor incidence in female mice.

Authors:  Marin E Healy; Sujoy Lahiri; Stefan R Hargett; Jenny D Y Chow; Frances L Byrne; David S Breen; Brandon M Kenwood; Evan P Taddeo; Carolin Lackner; Stephen H Caldwell; Kyle L Hoehn
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

Review 10.  High glucose: an emerging association between diabetes mellitus and cancer progression.

Authors:  Suangson Supabphol; Wunchana Seubwai; Sopit Wongkham; Charupong Saengboonmee
Journal:  J Mol Med (Berl)       Date:  2021-05-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.